NCT03824535View on ClinicalTrials.gov

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions
Cigarette SmokerCurrent SmokerFormer SmokerMultiple Pulmonary NodulesPulmonary Nodule
Interventions
DIAGNOSTIC_TEST

Computed Tomography

Undergo PET/CT

DRUG

Fludeoxyglucose F-18

Given IV

DRUG

Fluorine F 18 L-glutamate Derivative BAY94-9392

Given IV

DIAGNOSTIC_TEST

Positron Emission Tomography (PET/CT)

Undergo PET/CT

Trial Locations (1)

94304

Stanford Cancer Institute Palo Alto, Palo Alto

All Listed Sponsors
collaborator

Canary Foundation

OTHER

collaborator

Boston University

OTHER

collaborator

United States Department of Defense

FED

lead

Andrei Iagaru

OTHER

NCT03824535 - 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules | Biotech Hunter | Biotech Hunter